How They Won It: Lowenstein Breaks Ground With Schering Win

Law360, New York (July 10, 2012, 5:23 PM EDT) -- Attorneys for Lowenstein Sandler PC didn't just preserve a win for Schering-Plough Corp. in the Third Circuit in two putative class actions accusing the former drug giant of falsely marketing off-label uses for certain drugs, they also helped further clarify the pleading standards for plaintiffs established by the U.S. Supreme Court.

When a three-judge panel ruled in a precedential opinion that the plaintiffs failed to establish a plausible connection between Schering's alleged marketing campaign and their physicians' decision to prescribe oncology and hepatitis drugs for off-label...
To view the full article, register now.